
Product Lawyer
Who We Are:
Cogent Biosciences is a publicly traded biotechnology company dedicated to developing precision therapies for genetically defined diseases. By leveraging validated biology and a rational drug discovery approach, Cogent aims to create real solutions that address the underlying drivers of disease and offer meaningful hope to patient's.
The company’s lead therapeutic candidate, bezuclastinib, is a highly selective tyrosine kinase inhibitor designed to potently target KIT D816V and other mutations in KIT exon 17. These mutations are known drivers of systemic mastocytosis (SM) and advanced gastrointestinal stromal tumors (GIST) - both serious conditions driven by oncogenic KIT signaling. Bezuclastinib is currently being evaluated in multiple registration-directed trials across Non-Advanced SM (NonAdvSM), Advanced SM (AdvSM), and GIST. In July 2025, Cogent announced that its registration-direct SUMMIT trial in patients with NonAdvSM achieved statistical significance across all primary and key secondary endpoints, and the company is on track to file its first New Drug Application for this patient population by the end of 2025. The company also remains on track to announce top-line results for its APEX trial in patients with AdvSM in the second half of 2025 and for its PEAK trial in patients with GIST by the end of 2025. The company also has an ongoing Phase 1 study of its novel internally discovered FGFR2 inhibitor, and the Cogent Research Team is developing a portfolio of novel targeted therapies to help patients fighting other serious, genetically driven diseases targeting mutations in ErbB2, PI3Kα and KRAS.
Through its commitment to precision medicine and targeted innovation, Cogent Biosciences is working to transform the treatment landscape for patients with serious and underserved diseases. By leveraging validated biology and a rational drug discovery approach, Cogent aims to create real solutions that address the underlying drivers of disease. Our culture of inquisitiveness fuels continuous learning and innovation; we challenge assumptions, ask bold questions, and embrace a mindset of discovery to uncover transformative insights.
The Role:
- Provide strategic legal counsel as legal business partner across multiple departments as the company’s first in-house product attorney.
- Collaborate with the Commercial and Medical Affairs organizations to navigate legal challenges associated with product launch and market entry, with the opportunity to increase breadth of role over time.
- Advise on promotional, disease awareness, scientific communications, field sales training, and other outward-facing materials. Serve as Legal reviewer on promotional and medical materials review committees.
- Support contracting for Market Access, Patient Services, and other Commercial activities.
- Partner effectively with the broader Legal and Compliance teams, and with internal clients as a trusted strategic business partner.
- Develop and conduct training and periodic updates for internal teams on relevant topics and legal developments.
Qualifications:
- J.D. from an accredited law school and member in good standing of a state bar.
- Minimum 6 years’ legal experience in the biotechnology/pharmaceutical industry, including experience with an in-house legal department (law firm experience is a plus).
- This role is hybrid (two days a week in office in Waltham, MA); local candidates are strongly preferred.
- Prior experience advising a biopharmaceutical company through its initial commercial launch is highly preferred.
- Business partnering skills: demonstrated ability to partner effectively with growing and evolving Commercial and Medical Affairs teams to achieve business goals while mitigating legal risks; think strategically and analytically to solve legal issues in a pragmatic and efficient manner; and communicate those solutions clearly and concisely.
- Comprehensive understanding of healthcare and compliance laws and regulations, government pricing laws and implications, and commercial launch strategies.
- Broad experience in an emerging, publicly traded biopharmaceutical company environment is a plus.
- Ability to manage multiple tasks timelines in a fast-paced environment with attention to quality and detail.
- Strong interpersonal skills, including proven ability to interact and communicate effectively with individuals from multiple departments at all levels of the organization, including senior leadership.
- Commitment to professionalism and ethical conduct, including ability to handle confidential and/or sensitive information.
- Excellent verbal and written skills, allowing for an open and effective dialogue throughout the company.
Salary Range:
235,000 - 260,000 $USD
Apply for this job
*
indicates a required field